ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/05/2026
Back to search
Official data from USPTO
RELAPLUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
03/06/2026
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
06/21/2021
Registration date
09/13/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/13/2022
Last transaction
03/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
98
Owner location
IT
Examiner
FARRELL, ANNE M
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "RELAPLUS" in stylized font with "RELA" in green lettering and "PLUS" in orange lettering.
Holders and representatives
Holders
CRISTALFARMA S.r.l.
Representatives
John Zaccaria Notaro, Michalos & Zaccaria P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of gastrointestinal diseases and gastrointestinal disorders; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic substances, namely, dietetic preparations adapted for medical use; nutraceutical preparations for the treatment of gastrointestinal diseases and gastrointestinal disorders for therapeutic or medical purposes; albumin dietary supplements; protein dietary supplements; mineral food supplements; vitamin supplement patches; nutritional supplements; capsules for medicines, namely, capsules sold empty for pharmaceuticals; cachets for pharmaceutical purposes containing pharmaceutical preparations for the treatment of gastrointestinal diseases and gastrointestinal disorders; medicinal herbs; herbal extracts for medical purposes; plant extracts for pharmaceutical purposes; dietary fibre to aid digestion; medicines for human purposes in the nature of medicinal preparations for the treatment of gastrointestinal diseases and gastrointestinal disorders; phytotherapy preparations for medical purposes; vitamin preparations; chemico-pharmaceutical preparations for the treatment of gastrointestinal diseases and gastrointestinal disorders; medicinal roots; digestives for pharmaceutical purposes; fennel for medical purposes
Publications
History of USPTO decisions and trademark events.
35 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/09/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/16/2022
FIMP
FINAL DISPOSITION PROCESSED
12/16/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/13/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2022
PUBO
PUBLISHED FOR OPPOSITION
06/28/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/21/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/18/2022
ALIE
ASSIGNED TO LIE
05/16/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/16/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/16/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/16/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/18/2022
RFNT
REFUSAL PROCESSED BY IB
02/14/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/22/2022
RFRR
REFUSAL PROCESSED BY MPU
01/21/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/29/2021
CNRT
NON-FINAL ACTION WRITTEN
12/28/2021
DOCK
ASSIGNED TO EXAMINER
12/14/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/16/2021
Continuous trademark protection
Get notified about every new filing that threatens RELAPLUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.